Renaissance Technologies LLC Grows Stock Holdings in DocGo Inc. $DCGO

Renaissance Technologies LLC grew its position in shares of DocGo Inc. (NASDAQ:DCGOFree Report) by 167.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,510,361 shares of the company’s stock after acquiring an additional 944,826 shares during the period. Renaissance Technologies LLC owned about 1.53% of DocGo worth $950,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Neuberger Berman Group LLC bought a new stake in shares of DocGo in the fourth quarter worth about $29,000. Cerity Partners LLC bought a new position in DocGo during the 2nd quarter valued at approximately $37,000. Public Employees Retirement System of Ohio bought a new position in DocGo during the 4th quarter valued at approximately $40,000. Engineers Gate Manager LP purchased a new stake in DocGo in the 2nd quarter worth approximately $52,000. Finally, Jain Global LLC purchased a new stake in DocGo in the 4th quarter worth approximately $70,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Stock Performance

DocGo stock opened at $0.67 on Friday. The stock’s 50 day simple moving average is $0.60 and its two-hundred day simple moving average is $0.64. The stock has a market cap of $65.91 million, a price-to-earnings ratio of -0.35 and a beta of 0.99. DocGo Inc. has a fifty-two week low of $0.45 and a fifty-two week high of $1.73.

Wall Street Analysts Forecast Growth

DCGO has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a research report on Thursday, June 18th. Wall Street Zen raised DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Finally, Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $2.38.

Read Our Latest Analysis on DocGo

DocGo Profile

(Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Further Reading

Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGOFree Report).

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.